Center Laboratories, Inc. (TPEX:4123)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
39.30
-0.25 (-0.63%)
Apr 24, 2026, 1:30 PM CST
Market Cap29.34B +2.6%
Revenue (ttm)1.52B -6.3%
Net Income9.32B
EPS11.44
Shares Out746.53M
PE Ratio3.44
Forward PEn/a
Dividend0.71 (1.82%)
Ex-Dividend DateOct 3, 2025
Volume1,673,683
Average Volume2,672,700
Open39.80
Previous Close39.55
Day's Range39.10 - 39.85
52-Week Range32.26 - 51.40
Beta0.38
RSI40.34
Earnings DateApr 2, 2026

About Center Laboratories

Center Laboratories, Inc., a pharmaceutical company, develops, manufactures, and sells pharmaceuticals in Taiwan and internationally. The company offers general medication pharmaceuticals comprising antipyretic analgesics, bronchodilators, anti-inflammatory preparations, antihistamines, expectorants, narcotic antitussives and expectorants, gastrointestinal preparations, non-narcotic antitussives and expectorants, and other medicines. It also provides central nervous system medication consisting of treatments for cerebrovascular disease, dementi... [Read more]

Sector Healthcare
Founded 1959
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 4123
Full Company Profile

Financial Performance

Financial Statements